The pill manufactured by Pfizer-typically taken three times a day-was approved on the NHS in the early 1990s to treat nerve ...

Whether identifying as Republicans or Democrats, about 70% of adults surveyed say health insurers exert too much influence ...

It may be that patients have better control of cerebrovascular risk factors after the event, protecting against future ...

Duck Dynasty fans got to know Phil Robertson when the show aired on A&E from 2012 to 2017. However, when the series returned ...

Researchers have published a paper in Alzheimer's & Dementia, titled "ApoE3 Christchurch and tau interaction as a protective ...

People with "young" brains -- brains aging more slowly than their actual age -- are much less likely to die or develop ...

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Alzheimer’s and brain health deserve attention year-round, as millions are affected by dementia and related conditions.

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

Scientists at UCSF combined advanced brain-network modeling, genetics, and imaging to reveal how tau protein travels through ...

Following a Mediterranean diet long-term may have weight loss benefits but it may not be enough to enhance cognitive function ...

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...